Single-Agent Ibrutinib vs Real-World (RW) Treatments for Patients with Chronic Lymphocytic Leukemia (CLL) and del11q: Adjusted Comparison of RESONATE-2 (TM) and RESONATE (TM) with RW Databases

BLOOD

Salles, GA; Callet-Bauchu, E; Besson, H; Doyle, M; Garside, J; Spacek, M; Doubek, M, 2018: Single-Agent Ibrutinib vs Real-World (RW) Treatments for Patients with Chronic Lymphocytic Leukemia (CLL) and del11q: Adjusted Comparison of RESONATE-2 (TM) and RESONATE (TM) with RW Databases. BLOOD 132, doi: 10.1182/blood-2018-99-112172